Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety ...
Leadership
Robert Barrow
CEO & Director
Brandi L. Roberts CPA, M.B.A.
Chief Financial Officer
Daniel Rollings Karlin M.A., M.D.
Chief Medical Officer
Scott M. Freeman M.D.Founder
Co-Founder & Clinical Advisor
Leonard LatchmanFounder
Co-Founder
Peter Mack
Senior Vice President of Pharmaceutical Development & Operations
